Moxifloxacin HCI
Moxifloxacin hydrochloride is thus developed by Germany's bayer pharmaceutical a fluoroquinolone antibiotic medicine, action mechanism and the in vitro antibacterial spectrum similar to other fluoroquinolone drugs, but the antibacterial activity of gram positive bacteria and anaerobic bacteria and cut (trovafloChemicalbookxacin) similar characters, better than some of the old varieties.
| Supplier | CD Formulation |
|---|---|
| Product # | PAP-0064 |
| Pricing | , Inquire for price |
| Solubility | H2O: soluble5mg/mL, clear (warmed) |
| product1 | Antibacterial, Anti-inflammatory and Antiviral Series |
| Storage | 2-8°C |
| Molecular Formula | C21H25ClFN3O4 |
| Applications | It is an antibiotic used to treat bacterial infections of the lungs, paranasal sinuses, skin and abdominal cavity in adults. |
| Boiling Point | 636℃ |
| Melting Point | Slightly yellow to yellow crystalline powder, mp 324-325° |
| Molecular Weight (g/mol) | 437.8923032 |
| CAS Number | 186826-86-8 |
| Category | Antibiotic |
| Appearance | Powder |
| Standard | USP/EP |
| Grade | CEP/ISO |
| Color | white to beige |
| Physical State | powder |